Brimrose Technology Corp.
Brimrose Technology Corporation (BTC) is dedicated to transforming promising new technologies into real products that enhance lives. With a strong focus on research and development, BTC collaborates with major U.S. agencies to create innovative solutions in various fields, including defense, medical diagnostics, and environmental applications. The company has a proven track record of securing significant funding and contracts, demonstrating its commitment to advancing technology for critical applications.
Industries
N/A
Nr. of Employees
small (1-50)
Brimrose Technology Corp.
19 Loveton Circle, Hunt Valley Loveton Center, Sparks, MD. 21152
Products
Lateral flow assay diagnostic kits
Rapid screening assays for detection of pathogens and toxins including anthrax, plague, ricin, cholera, tularemia, botulism, and staph enterotoxin for environmental and clinical samples.
Bioluminescence ATP detection system
Systems for rapid detection of bacterial presence in human, environmental, surface, food, and water samples validated by FDA and USDA standards.
Hyperspectral imaging systems
Advanced acousto-optic tunable filter based imaging systems for real-time chemical and biological material identification.
CQD-based infrared focal plane arrays and cameras
Infrared detection cameras and focal plane arrays using colloidal quantum dots for short to long wavelength IR applications with potential for room temperature operation.
Mercurous halide semiconductor radiation detectors
Radiation detectors based on mercurous bromide crystals capable of detecting gamma and neutron radiation at room temperature with high resolution.
Acousto-optic modulators
Laser beam intensity, frequency modulation, and switching devices for applications from ultraviolet to long wave infrared frequencies.
Lateral flow assay diagnostic kits
Rapid screening assays for detection of pathogens and toxins including anthrax, plague, ricin, cholera, tularemia, botulism, and staph enterotoxin for environmental and clinical samples.
Bioluminescence ATP detection system
Systems for rapid detection of bacterial presence in human, environmental, surface, food, and water samples validated by FDA and USDA standards.
Hyperspectral imaging systems
Advanced acousto-optic tunable filter based imaging systems for real-time chemical and biological material identification.
CQD-based infrared focal plane arrays and cameras
Infrared detection cameras and focal plane arrays using colloidal quantum dots for short to long wavelength IR applications with potential for room temperature operation.
Mercurous halide semiconductor radiation detectors
Radiation detectors based on mercurous bromide crystals capable of detecting gamma and neutron radiation at room temperature with high resolution.
Acousto-optic modulators
Laser beam intensity, frequency modulation, and switching devices for applications from ultraviolet to long wave infrared frequencies.
Expertise Areas
- Chemical and biological agent detection
- Radiation detector development
- Photonics and acousto-optic technologies
- Rapid diagnostic assay development
Key Technologies
- Laser-induced breakdown spectroscopy
- Lateral flow immunoassays
- Semiconductor radiation detectors
- Hyperspectral imaging
News & Updates
Brimrose Technology has announced the availability of next-generation photodetectors for various applications.
Dr. Sudhir Trivedi has been recognized as a fellow by SPIE for his contributions to the field.
BTC has been awarded two Phase I and two Phase II SBIR/STTR grants totaling nearly $2 million, enhancing its R&D capabilities.
The BTC team has received a grant to develop solutions for Covid-19 detection and prevention.
BTC's Biotech Division has been awarded a contract to develop rapid tests for plague detection for U.S. soldiers.
BTC has received a patent for an improved data capturing sensor for military and security purposes.
Brimrose Technology has announced the availability of next-generation photodetectors for various applications.
Dr. Sudhir Trivedi has been recognized as a fellow by SPIE for his contributions to the field.
BTC has been awarded two Phase I and two Phase II SBIR/STTR grants totaling nearly $2 million, enhancing its R&D capabilities.
The BTC team has received a grant to develop solutions for Covid-19 detection and prevention.
BTC's Biotech Division has been awarded a contract to develop rapid tests for plague detection for U.S. soldiers.
BTC has received a patent for an improved data capturing sensor for military and security purposes.